Gut Microbiome and Metabonomic Profile Predict Early Remission to Anti-Integrin Therapy in Patients with Moderate to Severe Ulcerative Colitis
Microbiology Spectrum · 2023
DOI: 10.1128/spectrum.01457-23 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology Spectrum, 2023. Verfasst von Jie Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology o…. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Gastrointestinal Microbiome. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MOST | National Natural Science Foundation of China.
Abstract (Originalsprache)
It is reported that patients with ulcerative colitis (UC) have low response rates to anti-integrin medications in the latest VARSITY study. Therefore, our primary goals were to discover differences in the gut microbiome and metabonomics patterns between early remission and nonremission patients and to explore the diagnostic value in predicting clinical remission to anti-integrin therapy accurately.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, People's Republic of China.
- Endoscopy Center Department, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, People's Republic of China.
- Department of Nursing, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, People's Republic of China.
ORCID-Profile: Yue Yu
Förderung
- MOST | National Natural Science Foundation of China
Zitieren
APA
Liu, J., Fang, H., Hong, N., Lv, C., Zhu, Q., Feng, Y., Wang, B., Tian, J., & Yu, Y. (2023). Gut Microbiome and Metabonomic Profile Predict Early Remission to Anti-Integrin Therapy in Patients with Moderate to Severe Ulcerative Colitis. Microbiology Spectrum. https://doi.org/10.1128/spectrum.01457-23
Vancouver
Liu J, Fang H, Hong N, Lv C, Zhu Q, Feng Y, et al. Gut Microbiome and Metabonomic Profile Predict Early Remission to Anti-Integrin Therapy in Patients with Moderate to Severe Ulcerative Colitis. Microbiology Spectrum. 2023. doi:10.1128/spectrum.01457-23
BibTeX
@article{Liu2023,
author = {Liu, Jie and Fang, Huaying and Hong, Na and Lv, Chaolan and Zhu, Qihua and Feng, Yinping and Wang, Bo and Tian, Jiashuang and Yu, Yue},
title = {Gut Microbiome and Metabonomic Profile Predict Early Remission to Anti-Integrin Therapy in Patients with Moderate to Severe Ulcerative Colitis},
journal = {Microbiology Spectrum},
year = {2023},
doi = {10.1128/spectrum.01457-23}
}
EUVIMED